4.7 Article

A reciprocal relationship between reactive oxygen species and mitochondrial dynamics in neurodegeneration

Journal

REDOX BIOLOGY
Volume 14, Issue -, Pages 7-19

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.redox.2017.08.010

Keywords

Alzheimer's disease; beta-amyloid; Mitochondria; Fission and fusion; Drp-1; Neurodegeneration

Funding

  1. HKU [201511159237, 201611159183]
  2. Health and Medical Research Fund from Food and Health Bureau of Hong Kong SAR Government, HKU Alzheimer's Disease Research Network under Strategic Research Theme on Ageing [02131956]
  3. Faculty Core Facility at the LKS Faculty of Medicine, HKU
  4. Science and Technology Development Fund of Macao SAR [FDCT134/2014/A3]
  5. Research Committee-University of Macau [MYRG2016-00129-ICMS-QRCM]
  6. Hong Kong Polytechnic University G-YBRO
  7. 1-ZE5L

Ask authors/readers for more resources

Mitochondrial fragmentation due to fission/fusion imbalance has often been linked to mitochondrial dysfunction and apoptosis in neurodegeneration. Conventionally, it is believed that once mitochondrial morphology shifts away from its physiological tubular form, mitochondria become defective and downstream apoptotic signaling pathways are triggered. However, our study shows that beta-amyloid (A beta) induces morphological changes in mitochondria where they become granular-shaped and are distinct from fragmented mitochondria in terms of both morphology and functions. Accumulation of mitochondrial reactive oxygen species triggers granular mitochondria formation, while mitoTEMPO (a mitochondria-targeted superoxide scavenger) restores tubular mitochondrial morphology within A beta-treated neurons. Interestingly, modulations of mitochondria fission and fusion by genetic and pharmacological tools attenuated not only the induction of granular mitochondria, but also mitochondrial superoxide levels in A beta - treated neurons. Our study shows a reciprocal relationship between mitochondrial dynamics and reactive oxygen species and provides a new potential therapeutic target at early stages of neurodegenerative disease pathogenesis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available